Professor
Department of Medicine, Mackay Medical College, Taiwan
Ching-Hu Chung, PhD, Professor, Department of Medicine, Mackay Medical College
Education:
1996-2002 PhD in Pharmacology, College of Medicine, National Taiwan University
2003-2006 B.A. in Graduate Department of Law, Fu Jen Catholic University
1992-1996 B.A. in Pharmacy, Taipei Medical University
Publication
Chen HY, Shih JC, Tsai MH, Chung CH. Long-term survival and renal outcomes of thrombotic microangiopathy in pregnancy: A retrospective cohort study. Int J Gynaecol Obstet. 2023 Jun 14. doi: 10.1002/ijgo.14918. Online ahead of print.
Chi H, Chung CH. Respiratory Syncytial Virus Outbreak in Infants and Young Children during COVID-19 Pandemic in Taiwan. Children (Basel). 2023 Mar 28;10(4):629. doi: 10.3390/children10040629. PMID: 37189878
Chung CH, Wang YJ, Lee CY. One-Year Healthcare Utilization and Expenditures Among Patients with Clinically Significant Mitral Regurgitation in Taiwan. Cardiol Ther. 2023 Mar;12(1):159-169. doi: 10.1007/s40119-022-00294-2. Epub 2022 Dec 15. PMID: 36522569
Chung CH. Trends in pharmaceutical expenditure in the Taiwan National Health Insurance data base at different hospital levels. J Comp Eff Res. 2023 Feb;12(2):e220162. doi: 10.2217/cer-2022-0162. Epub 2022 Dec 13.
Chung CH, Wang YJ, Jiao X, Lee CY. Transcatheter aortic valve implantation vs. surgical aortic valve replacement for aortic stenosis in Taiwan: A population-based cohort study. PLoS One. 2023 May 3;18(5):e0285191. doi: 10.1371/journal.pone.0285191. eCollection 2023. PMID: 37134111
Chung CH, Tsai IJ, Tseng MH, Chou HH, Tain YL, Tsai JD, Chiou YY, Chiou YH, Lin CY. Clinical characteristics, triggering etiologies, and response of plasmapheresis in thrombotic microangiopathy in Taiwan. Medicine (Baltimore). 2021 May 21;100(20):e25986.doi: 10.1097/MD.0000000000025986.
Chung CH, Wang YJ and Lee CY. Epidemiology of heart valve disease in Taiwan: a population-based cohort study. International Heart Journal. 2021 v62 no5
Lin YJ, Chung CH, Chi H, Lin CH. Six-Monthly Palivizumab Prophylaxis Effectively Reduced RSV-associated Hospitalization Rates of Preterm Infants in a Subtropical Area - A Population-based Cohort Study. PEDIATRIC RESEARCH. Vol.19-No.06:1-25. Jun. 2019. (Co-first Author)